| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |